Home
Products & Services
Support
About
Contact Us
FinancialContent is the trusted provider of stock market information to the media industry.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Contrafect (NQ: CFRX)
0.3200 USD  -0.0021 (-0.65%)
Official Closing Price  /  Updated: 4:00 PM EDT, Oct 18, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 140,200
Open 0.3382
Bid (Size) 0.3100 (9)
Ask (Size) 0.3666 (3)
Prev. Close 0.3221
Today's Range 0.3150 - 0.3382
52wk Range 0.2693 - 2.630
Shares Outstanding 73,658,506
Dividend Yield N/A
Performance
YTD
-82.02%
-82.02%
1 Month
-23.21%
-23.21%
3 Month
-30.60%
-30.60%
6 Month
-36.00%
-36.00%
1 Year
-83.25%
-83.25%
Top News
More News
ContraFect Announces Plan for a Single Phase 3 Superiority Design Study of Exebacase Following Successful End-of-Phase 2 Meeting with FDA
from GlobeNewswire News Releases
ContraFect to Host Development Update Call and Webcast on October 2, 2019
from GlobeNewswire News Releases
More News
Read More
ContraFect to Present New Exebacase Data Including a Late Breaker Oral Presentation on the Reduction in Health Resource Utilization Among Exebacase-Treated MRSA Patients in the Recently Completed Phas
from GlobeNewswire News Releases
ContraFect to Present at the 2019 Janney Healthcare Conference
from GlobeNewswire News Releases
ContraFect Announces Presentation of New Data from its Amurin Peptide Program at the ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
from GlobeNewswire News Releases
ContraFect Reports Second Quarter 2019 Financial Results and Provides Business Update
from GlobeNewswire News Releases
X-Biotix Therapeutics Joins Antimicrobials Working Group
from PR Newswire
Antimicrobials Working Group Highlights Member Company Participation at ASM Microbe 2019
from PR Newswire
ContraFect Announces ASM Microbe 2019 Outstanding Abstract Award and Presentation of New Data
from GlobeNewswire News Releases
Antimicrobials Working Group Commends Senator Isakson and Senator Casey for Introducing Legislation to Improve Access to Innovative Therapies to Fight Drug-Resistant Infections
from PR Newswire
ContraFect Awarded $7.2 Million USAMRDC Grant to Support the Advancement of Lysin Candidate CF-296
from GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
   
© Copyright FinancialContent Services, Inc.